DR. NATHAN M BASS, MD
Osteopathic Medicine at Parnassus Ave, San Francisco, CA

License number

California A39874

Personal information

See more information about NATHAN M BASS at radaris.com

Name

Address

Phone

Nathan Bass

2665 Kremeyer Cir, Carlsbad, CA 92008

(760) 831-9958

Nathan Bass, age 74

3575 22Nd St, San Francisco, CA 94114

Nathan Bass, age 41

212 Jeffrey Dr, Sn Luis Obisp, CA 93405

Nathan M Bass

400 Parnassus Ave, San Francisco, CA 94143

(415) 353-2318
(415) 476-4937

Nathan M Bass, age 74

3575 22Nd St, San Francisco, CA 94114

(415) 821-1682

Professional information

Dr. Nathan M Bass, San Francisco CA - MD (Doctor of Medicine)

Specialties:

Gastroenterology

Address:

UCSF Liver Transplant Services
505 Parnassus Ave SUITE M896, San Francisco 94143
(415) 353-1888 (Phone)

Certifications:

Gastroenterology, 1991, Internal Medicine, 1983

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

UCSF Liver Transplant Services
505 Parnassus Ave SUITE M896, San Francisco 94143
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143

Education:

Medical School
University Of Cape Town, Faculty Of Health Sciences
Graduated: 1973
Groote Schuur Hospital
Graduated: 1974
Royal Free Hospital
Graduated: 1980
University Calif San Francisco
Graduated: 1983

Treatment Of Skin Conditions By Use Of Ppar Activators

US Patent:

RE37770, Jun 25, 2002

Filed:

Jan 8, 2001

Appl. No.:

09/756828

Inventors:

Peter M. Elias - Mill Valley CA
Nathan N. Bass - San Francisco CA
Karen Hanley - Mill Valley CA
Kenneth R. Feingold - San Rafael CA

Assignee:

The Regents of the University of California - Oaklland CA

International Classification:

A61K 3120

US Classification:

514560, 514256, 514543

Abstract:

Disorders of the skin and mucous membrane that have a disrupted or dysfunctional epidermal barrier are treated or prevented by topical application of compounds that are either activators of the farnesoid X receptor, activators of the peroxisome proliferator-activated receptor , and oxysterol activators of the LXR receptor. The same compounds are also effective in treating disorders of epidermal differentiation and proliferation.

Treatment Of Skin Conditions With Fxr Activators

US Patent:

6187814, Feb 13, 2001

Filed:

Oct 29, 1999

Appl. No.:

9/429070

Inventors:

Peter M. Elias - Mill Valley CA
Nathan N. Bass - San Francisco CA
Karen Hanley - Mill Valley CA
Kenneth R. Feingold - San Rafael CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61K 31215

US Classification:

514531

Abstract:

Disorders of the skin and mucous membranes that have a disrupted or dysfunctional epidermal barrier are treated or prevented by topical application of compounds that are either activators of the farnesoid X receptor, activators of the peroxisome proliferator-activated receptor. alpha. , and oxysterol activators of the LXR. alpha. receptor. The same compounds are also effective in treating disorders of epidermal differentiation and proliferation.

Professor Of Medicine At University Of California, San Francisco

Position:

Professor of Medicine at University of California, San Francisco

Location:

San Francisco Bay Area

Industry:

Medical Practice

Work:

University of California, San Francisco - Professor of Medicine

Nathan M Bass, San Francisco CA

Specialties:

Internist

Address:

350 Parnassus Ave, San Francisco, CA 94117

Education:

University of Cape Town, Faculty of Health Sciences - Doctor of Medicine
UCSF Medical Center - Fellowship - Gastroenterology (Internal Medicine)
The Royal Free Hospital - Residency - Internal Medicine

Board certifications:

American Board of Internal Medicine Certification in Internal Medicine

Nathan Michael Bass, San Francisco CA

Specialties:

Internal Medicine, Gastroenterology, General Practice

Work:

UCSF Medical Center / Moffitt-Long Hospitals
350 Parnassus Ave, San Francisco, CA 94117

Education:

University Of Cape Town (1973)

Treatment Of Skin Conditions With Oxysterol Activators Of Lxr.alpha.

US Patent:

6184215, Feb 6, 2001

Filed:

Aug 24, 1999

Appl. No.:

9/382031

Inventors:

Peter M. Elias - Mill Valley CA
Nathan N. Bass - San Francisco CA
Karen Hanley - Mill Valley CA
Kenneth R. Feingold - San Rafael CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61K 3156

US Classification:

514182

Abstract:

Treatment Of Skin Conditions By Use Of Ppar.alpha. Activators

US Patent:

6060515, May 9, 2000

Filed:

Jun 16, 1999

Appl. No.:

9/101366

Inventors:

Peter M. Elias - Mill Valley CA
Nathan N. Bass - San Francisco CA
Karen Hanley - Mill Valley CA
Kenneth R. Feingold - San Rafael CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61K 3120

US Classification:

514560

Abstract:

Disorders of the skin and mucous membrane that have a disrupted or dysfunctional epidermal barrier are treated or prevented by topical application of compounds that are either activators of the farnesoid X receptor, activators of the peroxisome proliferator-activated receptor. alpha. , and oxysterol activators of the LXR. alpha. receptor. The same compounds are also effective in treating disorders of epidermal differentiation and proliferation.